PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 123 filers reported holding PROVENTION BIO INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,155,328 | +443.3% | 213,914 | +138.3% | 0.01% | +400.0% |
| Q4 2022 | $948,869 | +493.0% | 89,770 | +151.6% | 0.00% | – |
| Q3 2022 | $160,000 | +14.3% | 35,677 | +1.0% | 0.00% | – |
| Q2 2022 | $140,000 | -48.3% | 35,331 | -4.7% | 0.00% | – |
| Q1 2022 | $271,000 | +26.6% | 37,080 | -2.8% | 0.00% | – |
| Q4 2021 | $214,000 | -5.7% | 38,161 | +6.9% | 0.00% | – |
| Q3 2021 | $227,000 | -13.4% | 35,707 | +14.6% | 0.00% | – |
| Q2 2021 | $262,000 | -30.1% | 31,166 | -12.9% | 0.00% | – |
| Q1 2021 | $375,000 | -53.5% | 35,775 | -24.9% | 0.00% | – |
| Q4 2020 | $807,000 | +159.5% | 47,614 | +96.4% | 0.00% | – |
| Q3 2020 | $311,000 | -7.2% | 24,240 | +2.1% | 0.00% | – |
| Q2 2020 | $335,000 | +67.5% | 23,747 | +8.8% | 0.00% | – |
| Q1 2020 | $200,000 | -89.2% | 21,820 | -82.4% | 0.00% | -100.0% |
| Q4 2019 | $1,844,000 | – | 123,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
| Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
| 683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
| Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
| Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
| Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
| Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |